Search
for
Sort by
Research 811–840 of 1000+
- Spironolactone Reduces Facial and Body Hair in Women with Hirsutism
- [Favorable effects of estrogens and progesterones on general diseases].
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Faculty Opinions recommendation of Bead-jet printing enabled sparse mesenchymal stem cell patterning augments skeletal muscle and hair follicle regeneration.
- Faculty Opinions recommendation of There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.
- Faculty Opinions recommendation of Mesotherapy with dutasteride for androgenetic alopecia: A retrospective study in real clinical practice.
- Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors
- Faculty Opinions recommendation of Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.
- Faculty Opinions recommendation of Therapeutic implications of topical cetirizine 1% in treatment of male androgenetic alopecia: A case-controlled study.
- Faculty Opinions recommendation of Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy.
- Faculty Opinions recommendation of Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
- Faculty Opinions recommendation of Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial.
- Faculty Opinions recommendation of Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
- Faculty Opinions recommendation of Symmetry breaking of tissue mechanics in wound induced hair follicle regeneration of laboratory and spiny mice.
- Faculty Opinions recommendation of Post-finasteride syndrome: a surmountable challenge for clinicians.
- Factors Influencing Depression in Korean Men with Androgenic Alopecia
- Comparison of Fatty Liver Disease in Men with and without Androgenetic Alopecia
- Serum Fatty Acid Binding Protein 4 in Patients with Androgenetic Alopecia
- Faculty Opinions recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”.
- Role of insulin-like growth factor-1 receptor in female androgenetic alopecia
- Prevalence, severity and associated factor of androgenetic alopecia in the dermatology outpatient clinic: A retrospective study
- Faculty Opinions recommendation of Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
- Faculty Opinions recommendation of Inhibition of β-catenin signalling in dermal fibroblasts enhances hair follicle regeneration during wound healing.
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Faculty Opinions recommendation of Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
- Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
- Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.
- Faculty Opinions recommendation of Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
- Faculty Opinions recommendation of Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.
- Faculty Opinions recommendation of Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?